Redness, irritation and scarring are all signs of properly functioning cellular processes,.  However in psoriatic individuals abnormally high levels of phosphorylase kinase are causing these processes to work to the extreme and without a switch-off mechanism to complete their job (the healing process).
 
Though abnormally high levels of phospohorylase kinase appear to be the cause of the persistance of psoriasis, current treatments do not address this problem and instead only suppress the cellular processes, offering little more than temporary relief.  Unfortunately, this relief lasts only as long as the treatment is being used.  On the other hand, a selective phosphorylase kinase inhibitor allows the cellular processes to start behaving like normal skin (before and after photography), and gives the person an opportunity to stop the persistence of psoriasis and stop treatment, as long as the aggravating factors are identified and a discipline is set into motion to avoid them in the future.

Dr. Madalene Heng developed curcumin gel, a phosphorylase kinase inhibitor to provide psoriatic individuals with an aid to compliment their existing treatment, not replace it.  To learn more, explore the menu to the left.